Tag: prostate cancer test

Attorney Jane Pine Wood to Be Chief Legal Counsel at Bio-Reference

By Robert Michel, from the Volume XXIII No. 13 – September 26, 2016 issue

One of the most widely-respected and trusted attorneys serving the clinical laboratory industry and anatomic pathology profession is leaving private practice to join the corporate world.
Effective October 1, 2016, Jane Pine Wood becomes the new Chief Legal Counsel and Compliance Officer for Bio-Reference Laboratories, Inc., of Elmwood Park, New Jersey. Wood will leave McDonald Hopkins, based in

View Article

Urologists Weigh in on Prostate Biopsy Testing

By Joseph Burns, from the Volume XX No. 3 - March 4, 2013 issue

CEO SUMMARY: Based on an impressive number of 4,230,129 vials collected from 437,937 biopsies, the new study is expected to add fuel to the fire of the ongoing debate about the appropriate number of prostate biopsies physicians should collect and refer to pathology labs for cancer testing. The researchers compared the number of prostate biopsies

View Article

Volume XXVI No. 2 – February 4, 2019

NOW THAT MOST HOSPITALS ARE INCLUDED as applicable laboratories that must report their PAMA private payer lab test price data to the Centers for Medicare and Medicaid Services, managers of those labs will benefit from the incisive analysis in this issue of the lessons learned during the 2017 PAMA reporting cycle. THE DARK REPORT further offers recommendations on how labs can do a better job of gathering and reporting their own data to CMS. Also, TDR delivers an exclusive analysis of why the Government Accounting Office's assertion that CMS will be paying billions more for Part B clinical lab tests is simply wrong.

See the full table of contents

Tag: prostate cancer test

Enter Your Login Credentials